Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion description "[Although advanced T stage and preoperative chemotherapy were statistically significant in univariate analysis, unmethylation of DAPK (p = 0.030) and hypermethylation of RARbetaP2 (p = 0.014), as well as advanced T stage (p = 0.075) and preoperative chemotherapy (p = 0.025), were significant risk factors in multivariate analysis for early recurrence in the remaining lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion evidence source_evidence_literature NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion SIO_000772 15797047 NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion wasDerivedFrom befree-20140225 NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion wasGeneratedBy ECO_0000203 NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.